MediciNova (MNOV)
(Delayed Data from NSDQ)
$1.14 USD
-0.02 (-1.72%)
Updated Aug 16, 2024 01:35 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for MediciNova, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 1 | 0 | 4 | 0 | 0 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 1 | 0 | 4 | 0 | 0 |
Selling & Adminstrative & Depr. & Amort Expenses | 11 | 15 | 14 | 14 | 14 |
Income After Depreciation & Amortization | -10 | -15 | -10 | -14 | -14 |
Non-Operating Income | 1 | 1 | 0 | 0 | 1 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -9 | -14 | -10 | -14 | -13 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -9 | -14 | -10 | -14 | -13 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -9 | -14 | -10 | -14 | -13 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -10 | -15 | -10 | -14 | -14 |
Depreciation & Amortization (Cash Flow) | 0 | 0 | 0 | 0 | 0 |
Income After Depreciation & Amortization | -10 | -15 | -10 | -14 | -14 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 49.05 | 49.05 | NA | 44.41 | NA |
Diluted EPS Before Non-Recurring Items | -0.17 | -0.29 | NA | -0.31 | NA |
Diluted Net EPS (GAAP) | -0.17 | -0.29 | -0.21 | -0.31 | -0.30 |
Fiscal Year end for MediciNova, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | 0.00 | 0.00 | 1.00 | 0.00 |
Cost Of Goods | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | NA | 0.00 | 0.00 | 1.00 | 0.00 |
SG&A, R&D, and Dept/Amort Expenses | 3.05 | 3.13 | 2.49 | 2.14 | 3.30 |
Income After SG&A, R&D, and Dept/Amort Expenses | -3.05 | -3.13 | -2.49 | -1.14 | -3.30 |
Non-Operating Income | 0.42 | 0.38 | 0.43 | 0.42 | 0.43 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | -2.63 | -2.75 | -2.06 | -0.72 | -2.87 |
Income Taxes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -2.63 | -2.75 | -2.05 | -0.72 | -2.87 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -2.63 | -2.75 | -2.05 | -0.72 | -2.87 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 49.05 | 51.48 | 49.05 | 49.05 |
Diluted EPS Before Non-Recurring Items | NA | -0.06 | -0.04 | -0.01 | -0.06 |
Diluted Net EPS (GAAP) | -0.05 | -0.06 | -0.04 | -0.01 | -0.06 |